If one reads the AGM announcement carefully, it does cover a lot of details about CAT, a very good read and I suggest everyone to give it a read. It will be worth something as CAT product fits the Chinese market very well. Its free shares anyway, so just let it sit in the bottom draw for now.
We should be expecting share price catalyst announcements soon? Animal trial results? Skin Cancer human trial to commence? Hudson ovian news update? plus others ?
Looks like support is at 1.7c at the moment, seems like plenty of patient buyers popping in 1m shares at 1.7m to support whenever it runs out...
.
Ann: Invion completes spin-out of respiratory assets, page-8
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
